Daniel L. Suzman
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
-
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
Papers in
-
- Prostate Cancer Treatment and Research 17
- Renal cell carcinoma treatment 10
- Prostate Cancer Diagnosis and Treatment 8
- Oncology 23
- Cancer Immunotherapy and Biomarkers 16
- Co-authors
- Richard Pazdur (33 shared papers)Emmanuel S. Antonarakis (15 shared papers)Shenghui Tang (23 shared papers)Gideon M. Blumenthal (4 shared papers)Dickran Kazandjian (3 shared papers)Patricia Keegan (3 shared papers)Kirsten B. Goldberg (9 shared papers)Kun He (1 shared paper)
- Journals
- Journal of Clinical Oncology (21 papers)Clinical Cancer Research (11 papers)The Oncologist (4 papers)AIDS (3 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesThailandJapan
In The Last Decade
Daniel L. Suzman
54 papers receiving 2.0k citations
Daniel L. Suzman's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 639
- Immunology 277
- Cancer Research 182
- Hepatology 59
Countries citing papers authored by Daniel L. Suzman
This map shows the geographic impact of Daniel L. Suzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Suzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Suzman more than expected).
Fields of papers citing papers by Daniel L. Suzman
This network shows the impact of papers produced by Daniel L. Suzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Suzman. The network helps show where Daniel L. Suzman may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel L. Suzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 351 | |
| 2 | 2019 | 237 | |
| 3 | 2018 | 160 | |
| 4 | FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2022 | 143 |
| 5 | 2018 | 142 | |
| 6 | 2020 | 133 | |
| 7 | 2017 | 117 | |
| 8 | 2017 | 113 | |
| 9 | 2014 | 80 | |
| 10 | 2017 | 71 | |
| 11 | 2014 | 59 | |
| 12 | 2024 | 37 | |
| 13 | 2019 | 35 | |
| 14 | 2014 | 30 | |
| 15 | 2003 | 29 | |
| 16 | 2015 | 29 | |
| 17 | 2017 | 24 | |
| 18 | 2003 | 24 | |
| 19 | 2016 | 21 | |
| 20 | 2020 | 20 |
About Daniel L. Suzman
Daniel L. Suzman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 62 papers that have together received 2.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), Bladder and Urothelial Cancer Treatments (11 papers), Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Economic and Financial Impacts of Cancer (6 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (639 citations), Immunology (277 citations), Cancer Research (182 citations) and Hepatology (59 citations). Daniel L. Suzman has collaborated with scholars based in United States, Thailand and Japan. Frequent co-authors include Richard Pazdur, Emmanuel S. Antonarakis, Shenghui Tang, Gideon M. Blumenthal, Dickran Kazandjian, Patricia Keegan, Kirsten B. Goldberg, Kun He, Sirisha L. Mushti and Chana Weinstock. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Oncologist, AIDS and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.